BertinaRMKoelemanBPCKosterTRosendaalFRDirvenRJde RondeHMutation in blood coagulation factor V associated with resistance to activated protein C. Nature1994; 369: 64–7.
2.
KoelemanBPCReitsmaPHAllaartCFBertinaRM.Activated Protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood1994; 4: 1031–5.
3.
JohnsonAHHartzmanRJRobinsonMA.HLA: the major histocompatibility complex. In: HenryJB, ed. Clinical Diagnosis and Management By Laboratory Methods.Philadelphia: WB Saunders, 1984; 790–805.
4.
KosterTRosendaalFRde RondeHBriëtEVandenbrouckeJPBertinaRM.Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet1993; 342: 1503–6.
5.
LindbladBSvensonPJDahlbäckB.Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet1994; 343: 917.
6.
SvenssonPJDahlbäckB.Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med.1994; 330: 517–22.